Congenica, the global diagnostic decision support platform provider, today announced a key partnership with the UK’s Epilepsy Society to study the genomics of sudden unexpected death in epilepsy (SUDEP). The new collaboration aims to […]
Cambridge, UK – 28 February 2018 – Congenica, a global provider of clinical genomics interpretation software announced today that it has received certification in ISO 13485:2016, a quality management system for medical […]
Cambridge, United Kingdom and Dublin, Ireland – 12 February 2018 – New software to deliver faster and more accurate diagnoses in genetic epilepsies is the ambition of a ground-breaking partnership between Congenica, a global provider of clinical genomics […]
“Rare Disease Diagnosis – Shortening Odysseys, Improving Outcomes,” presentation by Congenica at PMWC 2017, January 23
Whole genome analysis (WGA) enables rapid diagnosis of rare disease, ensuring that an appropriate course of management and treatment can […]
Accurate variant analysis facilitates personalised care pathways
The emergence of new therapies that treat the causes of cystic fibrosis is creating an imperative for more accurate variant analysis. To address this demand Elucigene Diagnostics, a […]
Sapientia Genome Interpretation. (Click to enlarge)
Congenica, a clinical interpretation partner for the UK 100,000 Genomes Project, has announced that its whole genome analysis […]
Dr Simon Ramsden
“In just one clinic, ophthalmology, we used to offer a genetic test to about 10-15 per cent of patients. Now all of […]
Congenica, a clinical interpretation partner for the 100,000 Genomes Project, has announced the successful delivery of diagnostic reports to the NHS Genomic Medicine Centres.
Genomics England has been working closely with three companies […]
As the use of whole genome and exome analysis grows it is increasing the workload for the Genomic Medicine Centres. In response to requests for improved support […]